ATYR PHARMA INC (ATYR) Stock Income Statement
NASDAQ:ATYR - Nasdaq - US0021202025 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 235.00K | 353.00K | 10.39M | 0.00 | |||
| Minority Interest Expense | 4.00K | -1.00K | 8.00K | 5.00K | 9.00K | |||
| Operating Expenses | 67.05M | 68.15M | 55.27M | 56.79M | 34.02M | |||
| Research and Development | 52.82M | 54.37M | 42.29M | 42.81M | 23.26M | |||
| Selling, General, and Administrative Expenses | 14.23M | 13.78M | 12.98M | 13.98M | 10.75M | |||
| Operating Income | -67.05M | -67.91M | -54.92M | -46.40M | -34.02M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Other Income/Expense | 3.63M | 3.89M | 4.52M | 1.06M | 238.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -63.42M | -64.02M | -50.40M | -45.34M | -33.78M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -63.41M | -64.02M | -50.39M | -45.34M | -33.77M | |||
| EBITDA | -66.35M | -67.21M | -54.33M | -46.17M | -33.54M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.81 | -0.86 | -0.94 | -1.60 | -1.77 | |||
| Non GAAP EPS | -0.81 | -0.87 | -0.96 | -1.60 | -1.88 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -27243.83% | -14274.50% | -436.53% | N/A | |||
| Operating Profit Margin | N/A | -28899.57% | -15557.79% | -446.79% | N/A | |||
All data in USD